Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Brian Moloney who wrote (2301)	4/3/1998 2:05:00 PM
From: WHL	Read Replies (1) \| Respond to of 3725

Brian and ALL: Nobody- even most cardiologists- knows about this technology. It is the best thing there is by at least 1000%. This will sell and sell and sell some more. How many cath labs and angio rooms in your community? Probably 1 per 100,000 people or so. In America there are at least 3,000 Ultrafast scanners needed NOW.

To: Brian Moloney who wrote (2301)	4/3/1998 2:27:00 PM
From: Bruce Rozenblit	Respond to of 3725

Your point about "standard of care" speaks volumes. Once that bench mark is achieved, this thing will sell like crazy lest swarms of frenzied lawyers will descend upon the non complying institutions like hoards of locusts. As I mentioned before several times, colonoscopy is an even bigger market because every body gets that procedure sooner or later as standard test. The drought may be over.

To: Brian Moloney who wrote (2301)	4/3/1998 7:16:00 PM
From: stock bull	Read Replies (1) \| Respond to of 3725

Brian, and ALL... I heard today on a local radio news broadcast, that a Florida firm announced that they have developed an ultrasound, low cost, machine that can be used to detect calcium deposits in the coronary arteries and detect small cancers. The cost per scan would be very low. This sounds like a threat to IMAT's X-Ray scanner. Do you know anything about the ultrasound scanner? Thanks for you comments. Stock Bull

To: Brian Moloney who wrote (2301)	4/4/1998 1:02:00 AM
From: John Zwiener	Respond to of 3725

Brian, I think this would be a welcome addition for GI workups for both radiologists and GI docs. Both would end up benefitting, as would the patient if used in the appropiate circumstances. The big item here is the cardiac scanning. There is no doubt in my mind that this can be of benefit in a very large population. There is no reason that cardiologists would fear this since they would get patients alive and with a longer life span, rather than waiting for them to arrive in crisis. the question is insurance companies and HMO's. These patients cost money. From their view point, prevention does usually cost money even if it benefits patients. But the population is so big and the benefits so clear, that politically, I'm not sure they can deny paying for this test when used appropriately. IMAT has great PR. They get rid of Siemans, and the news goes nuts! IMAT seems to know what they are doing (maybe they did a few screwy things a while back, true,,,but worth hanging in there for another year).

To: Brian Moloney who wrote (2301)	4/4/1998 1:39:00 PM
From: Robert Sherman	Respond to of 3725

Two points that I would like to make regarding IMAT. Firstly, it has broken out of a base formation very nicely. Tehcnical analysis on this chart says that it will go much higer from here. It has broken out on very high volume, over 12 times daily average. That is very positive. Look for more buyers in the future. Secondly, A lot of naysayer's on this board have forgotten about the possibility that this company could get bought out. Instead of reinventing the wheel, somebody could purchase this company for a relatively inexpensive price. -Robert.